I
Inhibikase Therapeutics, Inc. (IKT)
NCM – Real vaqt narxi. Valyuta: USD
1.91
+0.04 (2.14%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.92
+0.01 (0.52%)
Bozordan keyin: Jun 26, 2026, 5:21 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.91
+0.04 (2.14%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.92
+0.01 (0.52%)
Bozordan keyin: Jun 26, 2026, 5:21 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 30.14 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 30.14 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.00 | 0.30 | 10 | |
| Qarz/Aktivlar nisbati | 0.00 | 1.04 | 10 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 8.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 123K | 261K | N/A | N/A | N/A |
| Yalpi foyda | 117K | 83K | -26K | -60K | -48K |
| Operatsion daromad | -18M | -20M | -29M | -46M | -56M |
| Sof foyda | -18M | -19M | -28M | -48M | -51M |
| EBITDA | -18M | -20M | -29M | -46M | -56M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 3.9 | 2.5 |
| Keyingi chorak | N/A | 18.68 | 5.0 |
| Joriy yil | N/A | 14.87 | 4.5 |
| Keyingi yil | 33.33 | -5.82 | 5.5 |
| O‘rtacha ball | 4.4 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | -28.62 | 0 | -60.44 | 3.3 |
| Yil/Yil | 999 | -19.74 | 33.33 | -192.92 | 5.5 |
| 3 yil o‘rtacha | 336.68 | -41.77 | 47.54 | -17.93 | 5.5 |
| 5 yil o‘rtacha | 251.59 | -113.31 | 4.46 | -248.55 | 4.0 |
| O‘rtacha ball | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Naqd pul zahiralari $49.6M kelgusi qarz to'lovlarini $0.0 zo'rg'a qoplaydi
Jami joriy aktivlar $172.2M jami joriy majburiyatlardan $5.7M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$12.1M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi